Evaluation Effects of Nasal Nitric Oxide Measurements Are Associated With Atopy Status in Chronic Nasal Inflammation
NCT01295866
Hypersensitivity, Immune System Diseases
View Trial DetailsNCT Number: NCT02879929
Nasal symptoms are the main elements that lead to a therapeutic decision and allow for evaluating treatment effects or natural evolution. Despite availability of several questionnaires with good measurement qualities, no systematic assessment takes into account the specific physical and psychosocial consequences of each of the six main nasal symptoms, independently of the disease. The study proposed to measure these symptoms with the use of a selfreport questionnaire and to test the validity of the questionnaire in a large representative sample of patients attending outpatient rhinologic clinics.
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
The study was conducted in two parts: (1) expert-based development and testing of the face validity of a questionnaire in French; and (2) validity testing, including construct validity by factor analysis, reproducibility by intraclass correlation coefficient (ICC) and Bland and Altman plots, and sensitivity to change by standardized response means, on a large sample of patients in a prospective multicenter study. DyNaChron, a questionnaire with 78 items divided into six domains and exploring both the physical and psychosocial repercussions of CND, was developed. In total, 759 patients completed the questionnaire at a first visit to a clinic, and 539 again 19.5 days later, on average.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Patients had to
Exclusion criteria
Time frame: 6 months
to develop a self-report questionnaire to assess nose and sinus functional symptoms together with their consequences for physical and psychosocial areas
Time frame: 10 months
to test the validity of the new instrument developped in a large representative sample of patients attending outpatient rhinology clinics
Central Hospital, Nancy, France
Other
Acronym: DyNaChron
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT01295866
Hypersensitivity, Immune System Diseases
View Trial DetailsNCT02784262
Bites and Stings, Chemically-Induced Disorders
Trondheim, Norway
View Trial DetailsNCT06448585
Allergic Rhinoconjunctivitis, Controlled Asthma
Don Benito, Badajoz, Spain
View Trial DetailsNCT07140250
Airway Obstruction, Infections
La Jolla, California, United States
View Trial Details